Woods J W, Pittman A W, Pulliam C C, Werk E E, Waider W, Allen C A
N Engl J Med. 1976 May 20;294(21):1137-43. doi: 10.1056/NEJM197605202942101.
We compared methods of classifying hypertension according to plasma renin activity in 54 patients with essential hypertension and examined the validity of using these classifications to choose between two hypotensive drugs. A prospective, double-blind crossover study was used. Normal values for plasma renin activity were established from 111 control subjects. Plasma renin activity was related to race and inversely to age in hypertensive patients (P less than 0.05) but not in normal subjects. Three methods of classification correlated well but did not identify exactly the same renin-suppressed patients. Chlorthalidone produced a greater reduction in blood pressure and restored blood pressure to normal in a larger percentage of patients in both low-renin (59 per cent) and normal-renin (32 per cent) subgroups than propranolol (12 and 16 per cent). Renin determinations are of limited benefit in the choice of therapy for most patients with essential hypertension.
我们比较了54例原发性高血压患者根据血浆肾素活性对高血压进行分类的方法,并检验了使用这些分类在两种降压药物之间进行选择的有效性。采用前瞻性双盲交叉研究。从111名对照受试者中确定血浆肾素活性的正常值。在高血压患者中,血浆肾素活性与种族相关,与年龄呈负相关(P<0.05),但在正常受试者中并非如此。三种分类方法相关性良好,但并未精确识别出相同的肾素抑制患者。在低肾素(59%)和正常肾素(32%)亚组中,氯噻酮使血压降低幅度更大,且使更大比例的患者血压恢复正常,比普萘洛尔(12%和16%)效果更好。对于大多数原发性高血压患者,肾素测定在治疗选择中的益处有限。